These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 8222874
1. Efficacy and tolerance of erythromycin acistrate in the treatment of acute exacerbations of chronic bronchitis in the elderly. Forsén KO, Wikberg R, Lehtonen L. Chemotherapy; 1993; 39(6):443-52. PubMed ID: 8222874 [Abstract] [Full Text] [Related]
2. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis. Zeckel ML, Jacobson KD, Guerra FJ, Therasse DG, Farlow D. Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645 [Abstract] [Full Text] [Related]
3. Cefpodoxime proxetil in the treatment of lower respiratory tract infections. Geddes AM. Drugs; 1991; 42 Suppl 3():34-40. PubMed ID: 1726206 [Abstract] [Full Text] [Related]
4. Comparison of erythromycin acistrate and enterocoated erythromycin base in acute respiratory infections. Gordin A, Kalima S, Hulmi S, Mäkelä P, Antikainen R. J Antimicrob Chemother; 1988 Jun; 21 Suppl D():85-92. PubMed ID: 3391879 [Abstract] [Full Text] [Related]
5. Erythromycin acistrate and enterocoated pellets of erythromycin base in acute respiratory infections of hospitalized conscripts. Gordin A, Salmi HA, Antikainen R. J Antimicrob Chemother; 1988 Jun; 21 Suppl D():93-9. PubMed ID: 3391881 [Abstract] [Full Text] [Related]
6. Twice daily dosing of erythromycin acistrate in the treatment of acute bronchitis and pneumonia. Wiesner B, Wilen-Rosenqvist G, Lehtonen L. Arzneimittelforschung; 1993 Sep; 43(9):1014-7. PubMed ID: 8240450 [Abstract] [Full Text] [Related]
7. A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections. Hoepelman AI, Sips AP, van Helmond JL, van Barneveld PW, Neve AJ, Zwinkels M, Rozenberg-Arska M, Verhoef J. J Antimicrob Chemother; 1993 Jun; 31 Suppl E():147-52. PubMed ID: 8396086 [Abstract] [Full Text] [Related]
8. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group. DeAbate CA, Henry D, Bensch G, Jubran A, Chodosh S, Harper L, Tipping D, Talbot GH. Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458 [Abstract] [Full Text] [Related]
9. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis. Dere WH, Farlow D, Therasse DG, Jacobson KD, Guerra FJ. Clin Ther; 1992 Jul; 14(2):166-77. PubMed ID: 1611641 [Abstract] [Full Text] [Related]
10. Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections. Dark D. Am J Med; 1991 Sep 12; 91(3A):31S-35S. PubMed ID: 1656740 [Abstract] [Full Text] [Related]
11. Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis. Cazzola M, Di Perna F, Boveri B, Di Marco F, Diamare F, Centanni S. J Chemother; 2000 Jun 12; 12(3):216-22. PubMed ID: 10877516 [Abstract] [Full Text] [Related]
12. Treatment of respiratory tract infections with erythromycin acistrate and two formulations of erythromycin base. Wuolijoki E, Flygare U, Hildén M, Hurme J, Järvinen H, Leskinen J, Pynnönen S, Riikonen A, Salomaa V, Seuri M. J Antimicrob Chemother; 1988 Jun 12; 21 Suppl D():107-12. PubMed ID: 3391872 [Abstract] [Full Text] [Related]
13. Erythromycin and bromhexine in acute exacerbations of chronic bronchitis. A study on sputum penetration and clinical effectiveness. Maesen FP, Davies BI, Brouwers J, Rubingh G. Eur J Respir Dis; 1982 Jul 12; 63(4):325-9. PubMed ID: 6981522 [Abstract] [Full Text] [Related]
14. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis. Cazzola M, Vinciguerra A, Di Perna F, Califano C, Calderaro F, Salzillo A, Centanni S. J Chemother; 1999 Apr 12; 11(2):119-25. PubMed ID: 10326742 [Abstract] [Full Text] [Related]
15. Twice daily dosage of bacampicillin in chronic bronchitis. A double-blind study. Davies BI, Maesen FP, Brombacher PJ, Sjövall J. Scand J Respir Dis; 1978 Oct 12; 59(5):249-56. PubMed ID: 32615 [Abstract] [Full Text] [Related]
16. Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis. Wasilewski MM, Johns D, Sides GD. J Antimicrob Chemother; 1999 Apr 12; 43(4):541-8. PubMed ID: 10350384 [Abstract] [Full Text] [Related]
17. Erythromycin in acute laryngitis in adults. Schalén L, Eliasson I, Kamme C, Schalén C. Ann Otol Rhinol Laryngol; 1993 Mar 12; 102(3 Pt 1):209-14. PubMed ID: 8457123 [Abstract] [Full Text] [Related]
18. Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis. Davies BI, Maesen FP, Baur C. Eur J Clin Microbiol; 1986 Apr 12; 5(2):226-31. PubMed ID: 2941287 [Abstract] [Full Text] [Related]
19. Cefaclor AF versus cefaclor in acute exacerbations of chronic bronchitis. Grossman RF. Postgrad Med J; 1992 Apr 12; 68 Suppl 3():S30-6; discussion S36-7. PubMed ID: 1287616 [Abstract] [Full Text] [Related]
20. Erythromycin acistrate and erythromycin stearate in the treatment of non-gonococcal urethritis. Rostila T, Visa K, Gordin A, Antikainen R. J Antimicrob Chemother; 1988 Jun 12; 21 Suppl D():113-9. PubMed ID: 3391873 [Abstract] [Full Text] [Related] Page: [Next] [New Search]